TFEB and mucopolysaccharidosis type 3A: Capuozzo and co-workers [59] also highlighted the central role of TFEB in treating mucopolysaccharidosis type IIIA (MPS IIIA), a disease associated with the accumulation of heparan sulfate and progressive neurodegenerative symptoms.